9.305 USD
-0.02 (-0.16%)
GRFS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. GRFS has an excellent profitability rating, but there are some minor concerns on its financial health. GRFS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
GRFS had positive earnings in the past year.
GRFS had a positive operating cash flow in the past year.
In the past 5 years GRFS has always been profitable.
In multiple years GRFS reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of GRFS (1.88%) is better than 89.06% of its industry peers.
With an excellent Return On Equity value of 7.20%, GRFS belongs to the best of the industry, outperforming 91.32% of the companies in the same industry.
GRFS has a better Return On Invested Capital (4.93%) than 91.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GRFS is significantly below the industry average of 18.28%.
The last Return On Invested Capital (4.93%) for GRFS is above the 3 year average (2.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.88% | ||
| ROE | 7.2% | ||
| ROIC | 4.93% |
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
1.3 Margins
GRFS has a better Profit Margin (4.96%) than 89.43% of its industry peers.
GRFS's Profit Margin has declined in the last couple of years.
The Operating Margin of GRFS (18.06%) is better than 94.15% of its industry peers.
GRFS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 39.09%, GRFS is in the better half of the industry, outperforming 73.77% of the companies in the same industry.
In the last couple of years the Gross Margin of GRFS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.06% | ||
| PM (TTM) | 4.96% | ||
| GM | 39.09% |
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GRFS is destroying value.
Compared to 1 year ago, GRFS has about the same amount of shares outstanding.
GRFS has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for GRFS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.33, we must say that GRFS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GRFS (1.33) is better than 64.53% of its industry peers.
GRFS has a debt to FCF ratio of 13.86. This is a negative value and a sign of low solvency as GRFS would need 13.86 years to pay back of all of its debts.
GRFS has a Debt to FCF ratio of 13.86. This is amongst the best in the industry. GRFS outperforms 90.19% of its industry peers.
GRFS has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GRFS (1.76) is worse than 77.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.76 | ||
| Debt/FCF | 13.86 | ||
| Altman-Z | 1.33 |
ROIC/WACC0.97
WACC5.1%
2.3 Liquidity
A Current Ratio of 2.48 indicates that GRFS has no problem at all paying its short term obligations.
With a Current ratio value of 2.48, GRFS is not doing good in the industry: 70.57% of the companies in the same industry are doing better.
GRFS has a Quick Ratio of 2.48. This is a bad value and indicates that GRFS is not financially healthy enough and could expect problems in meeting its short term obligations.
GRFS has a worse Quick ratio (0.93) than 86.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 160.05% over the past year.
The earnings per share for GRFS have been decreasing by -23.99% on average. This is quite bad
The Revenue has been growing slightly by 7.31% in the past year.
The Revenue has been growing slightly by 7.18% on average over the past years.
EPS 1Y (TTM)160.05%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%133.5%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%4.04%
3.2 Future
GRFS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.80% yearly.
The Revenue is expected to grow by 6.19% on average over the next years.
EPS Next Y41.68%
EPS Next 2Y32.76%
EPS Next 3Y30.55%
EPS Next 5Y22.8%
Revenue Next Year5.37%
Revenue Next 2Y5.26%
Revenue Next 3Y5.69%
Revenue Next 5Y6.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.54, GRFS is valued correctly.
Based on the Price/Earnings ratio, GRFS is valued cheaper than 96.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of GRFS to the average of the S&P500 Index (26.87), we can say GRFS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 8.18, the valuation of GRFS can be described as reasonable.
99.25% of the companies in the same industry are more expensive than GRFS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of GRFS to the average of the S&P500 Index (23.46), we can say GRFS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.54 | ||
| Fwd PE | 8.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GRFS indicates a rather cheap valuation: GRFS is cheaper than 97.74% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GRFS indicates a rather cheap valuation: GRFS is cheaper than 99.25% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.71 | ||
| EV/EBITDA | 7.85 |
4.3 Compensation for Growth
GRFS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GRFS may justify a higher PE ratio.
GRFS's earnings are expected to grow with 30.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y32.76%
EPS Next 3Y30.55%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.44%, GRFS is a good candidate for dividend investing.
GRFS's Dividend Yield is rather good when compared to the industry average which is at 1.20. GRFS pays more dividend than 99.25% of the companies in the same industry.
GRFS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.44% |
5.2 History
The dividend of GRFS decreases each year by -66.87%.
GRFS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-66.87%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.73% of the earnings are spent on dividend by GRFS. This is a low number and sustainable payout ratio.
DP27.73%
EPS Next 2Y32.76%
EPS Next 3Y30.55%
NASDAQ:GRFS (1/6/2026, 11:50:58 AM)
9.305
-0.02 (-0.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners31.55%
Inst Owner Change0%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap6.33B
Revenue(TTM)7.52B
Net Income(TTM)372.72M
Analysts75
Price Target13 (39.71%)
Short Float %2.32%
Short Ratio10.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.44% |
Yearly Dividend0
Dividend Growth(5Y)-66.87%
DP27.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.15%
PT rev (3m)-4.92%
EPS NQ rev (1m)-1.29%
EPS NQ rev (3m)-0.1%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-3.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.54 | ||
| Fwd PE | 8.18 | ||
| P/S | 0.72 | ||
| P/FCF | 7.71 | ||
| P/OCF | 4.77 | ||
| P/B | 1.04 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.85 |
EPS(TTM)0.64
EY6.88%
EPS(NY)1.14
Fwd EY12.23%
FCF(TTM)1.21
FCFY12.97%
OCF(TTM)1.95
OCFY20.98%
SpS12.98
BVpS8.94
TBVpS-9.21
PEG (NY)0.35
PEG (5Y)N/A
Graham Number11.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.88% | ||
| ROE | 7.2% | ||
| ROCE | 7.67% | ||
| ROIC | 4.93% | ||
| ROICexc | 5.17% | ||
| ROICexgc | 13.72% | ||
| OM | 18.06% | ||
| PM (TTM) | 4.96% | ||
| GM | 39.09% | ||
| FCFM | 9.3% |
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
ROICexc(3y)3.07%
ROICexc(5y)3.33%
ROICexgc(3y)6.89%
ROICexgc(5y)7.47%
ROCE(3y)4.51%
ROCE(5y)4.82%
ROICexgc growth 3Y11.6%
ROICexgc growth 5Y-8.62%
ROICexc growth 3Y14.21%
ROICexc growth 5Y-7.74%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
F-Score7
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.76 | ||
| Debt/FCF | 13.86 | ||
| Debt/EBITDA | 5.08 | ||
| Cap/Depr | 99.96% | ||
| Cap/Sales | 5.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 63.19% | ||
| Profit Quality | 187.58% | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 1.33 |
F-Score7
WACC5.1%
ROIC/WACC0.97
Cap/Depr(3y)62.1%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.39%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.05%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%133.5%
EPS Next Y41.68%
EPS Next 2Y32.76%
EPS Next 3Y30.55%
EPS Next 5Y22.8%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%4.04%
Revenue Next Year5.37%
Revenue Next 2Y5.26%
Revenue Next 3Y5.69%
Revenue Next 5Y6.19%
EBIT growth 1Y35.86%
EBIT growth 3Y27.11%
EBIT growth 5Y0.58%
EBIT Next Year44.75%
EBIT Next 3Y20.41%
EBIT Next 5Y16.88%
FCF growth 1Y-79.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-168.33%
OCF growth 3YN/A
OCF growth 5YN/A
GRIFOLS SA-ADR / GRFS FAQ
Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to GRFS.
What is the valuation status of GRIFOLS SA-ADR (GRFS) stock?
ChartMill assigns a valuation rating of 9 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.
What is the profitability of GRFS stock?
GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for GRFS stock?
The Price/Earnings (PE) ratio for GRIFOLS SA-ADR (GRFS) is 14.54 and the Price/Book (PB) ratio is 1.04.
What is the financial health of GRIFOLS SA-ADR (GRFS) stock?
The financial health rating of GRIFOLS SA-ADR (GRFS) is 4 / 10.